This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cochereau-Massin, I Articles by Pocidalo, J J Search for Related Content PubMed PubMed Citation Articles by Cochereau-Massin, I Articles by Pocidalo, J J

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1993 April; 37(4): 633-636

Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis.

Institut National de la Santé et de la Recherche Médicale U13, Hôpital Claude Bernard, Paris, France.

ABSTRACT

Gram-positive cocci are the most common pathogens in severe human eye infections. Streptococcal endophthalmitis is a devastating infection, and intravitreal antibiotic therapy is limited by retinal toxicity. Because few systemic antistreptococcal antibiotics penetrate into the vitreous, sparfloxacin, a newer quinolone with improved antistreptococcal activity, might be of interest. We therefore assessed its efficacy by the intravitreal route in a rabbit model of streptococcal endophthalmitis. The vitreal bacterial count (mean +/- standard deviation log10 CFU per milliliter) was significantly reduced after an intravitreal injection of 800 micrograms of sprafloxacin (4.9 +/- 0.7) relative to the counts in untreated control (7.1 +/- 0.7) and pefloxacin-treated (7.8 +/- 1.2) eyes. After systemic administration to rabbits, the maximum concentration of sparfloxacin in serum was 5.6 micrograms.ml-1 and the half-life was 7.5 h. Sparfloxacin exhibited very good penetration ratios in the vitreous (54%), cornea (76%), and lens (36%). In the vitreous, the levels of sparfloxacin remained greater than the MICs for most gram-positive cocci for up to 18 h. Further experimental studies are warranted to determine the efficacy of systemic sparfloxacin as adjuvant therapy in the treatment of human endophthalmitis.

This article has been cited by other articles:

• Perez, S., Solans, C., Bregante, M. A., Pinilla, I., Garcia, M. A., Honrubia, F. (2002). Pharmacokinetics and ocular penetration of grepafloxacin in albino and pigmented rabbits. J Antimicrob Chemother 50: 541-545 [Abstract] [Full Text]  
• Liu, W., Liu, Q. F., Perkins, R., Drusano, G., Louie, A., Madu, A., Mian, U., Mayers, M., Miller, M. H. (1998). Pharmacokinetics of Sparfloxacin in the Serum and Vitreous Humor of Rabbits: Physicochemical Properties That Regulate Penetration of Quinolone Antimicrobials. Antimicrob. Agents Chemother. 42: 1417-1423 [Abstract] [Full Text]